清晨好,您是今天最早来到科研通的研友!由于当前在线用户较少,发布求助请尽量完整地填写文献信息,科研通机器人24小时在线,伴您科研之路漫漫前行!

Frequency and Clinical Outcomes Associated With Tau Positron Emission Tomography Positivity

医学 痴呆 正电子发射断层摄影术 临床痴呆评级 内科学 认知障碍 核医学 疾病
作者
Alexis Moscoso,Fiona Heeman,Sheelakumari Raghavan,Alejandro Costoya‐Sánchez,Martijn van Essen,Ismini Mainta,Valle Camacho,Omar Darío Rodríguez-Fonseca,Jesús Silva‐Rodríguez,Andrés Perissinotti,Yuna Gu,Jihwan Yun,Débora Elisa Peretti,Federica Ribaldi,Emma M. Coomans,Wagner S. Brum,Michel J. Grothe,Pablo Aguiar,Gérard N. Bischof,Alexander Drzezga
出处
期刊:JAMA [American Medical Association]
标识
DOI:10.1001/jama.2025.7817
摘要

Importance Tau positron emission tomography (PET) allows in vivo detection of neurofibrillary tangles, a core neuropathologic feature of Alzheimer disease (AD). Objective To provide estimates of the frequency of tau PET positivity and its associated risk of clinical outcomes. Design, Setting, and Participants Longitudinal study using data pooled from 21 cohorts, comprising a convenience sample of 6514 participants from 13 countries, collected between January 2013 and June 2024. Cognitively unimpaired individuals and patients with a clinical diagnosis of mild cognitive impairment (MCI), AD dementia, or other neurodegenerative disorders were included. Exposures Tau PET with flortaucipir F 18, amyloid-β (Aβ) PET, and clinical examinations. Tau PET scans were visually rated as positive according to a US Food and Drug Administration– and European Medicines Agency–approved method, designed to indicate the presence of advanced neurofibrillary tangle pathology (Braak stages V-VI). Main Outcomes and Measures Frequency of tau PET positivity and absolute risk of clinical progression (eg, progression to MCI or dementia). Results Among the 6514 participants (mean age, 69.5 years; 50.5% female), median follow-up time ranged from 1.5 to 4.0 years. Of 3487 cognitively unimpaired participants, 349 (9.8%) were tau PET positive; the estimated frequency of tau PET positivity was less than 1% in those aged younger than 50 years, and increased from 3% (95% CI, 2%-4%) at 60 years to 19% (95% CI, 16%-24%) at 90 years. Tau PET positivity frequency estimates increased across MCI and AD dementia clinical diagnoses (43% [95% CI, 41%-46%] and 79% [95% CI, 77%-82%] at 75 years, respectively). Most tau PET–positive individuals (92%) were also Aβ PET positive. Cognitively unimpaired participants who were positive for both Aβ PET and tau PET had a higher absolute risk of progression to MCI or dementia over the following 5 years (57% [95% CI, 45%-71%]) compared with both Aβ PET–positive/tau PET–negative (17% [95% CI, 13%-22%]) and Aβ PET–negative/tau PET–negative (6% [95% CI, 5%-8%]) individuals. Among participants with MCI at the time of the tau PET scan, an Aβ PET–positive/tau PET–positive profile was associated with a 5-year absolute risk of progression to dementia of 70% (95% CI, 59%-81%). Conclusions and Relevance In a large convenience sample, a positive tau PET scan occurred at a nonnegligible rate among cognitively unimpaired individuals, and the combination of Aβ PET positivity and tau PET positivity was associated with a high risk of clinical progression in both preclinical and symptomatic stages of AD. These findings underscore the potential of tau PET as a biomarker for staging AD pathology.
最长约 10秒,即可获得该文献文件

科研通智能强力驱动
Strongly Powered by AbleSci AI
更新
PDF的下载单位、IP信息已删除 (2025-6-4)

科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
sxwzssyj完成签到,获得积分10
1秒前
haralee完成签到 ,获得积分10
4秒前
济民财完成签到,获得积分10
8秒前
我是笨蛋完成签到 ,获得积分10
26秒前
氟锑酸完成签到 ,获得积分10
26秒前
刘剑完成签到,获得积分10
33秒前
1分钟前
SciGPT应助科研通管家采纳,获得10
1分钟前
传奇3应助科研通管家采纳,获得10
1分钟前
lulu123发布了新的文献求助10
1分钟前
北国雪未消完成签到 ,获得积分10
1分钟前
充电宝应助lulu123采纳,获得30
1分钟前
拉长的秋白完成签到 ,获得积分10
1分钟前
年轻千愁完成签到 ,获得积分10
1分钟前
DJ_Tokyo完成签到,获得积分0
1分钟前
hi_traffic完成签到,获得积分10
2分钟前
myq完成签到 ,获得积分10
2分钟前
gmc完成签到 ,获得积分10
2分钟前
白昼の月完成签到 ,获得积分0
2分钟前
Xu完成签到,获得积分10
2分钟前
庄怀逸完成签到 ,获得积分10
2分钟前
fang应助科研通管家采纳,获得10
3分钟前
fang应助科研通管家采纳,获得10
3分钟前
fang应助科研通管家采纳,获得10
3分钟前
fang应助科研通管家采纳,获得10
3分钟前
一路有你完成签到 ,获得积分10
3分钟前
高高应助豪士赋采纳,获得10
3分钟前
3分钟前
恒牙完成签到 ,获得积分10
3分钟前
科研通AI2S应助Xu采纳,获得10
3分钟前
nihao完成签到 ,获得积分10
3分钟前
豪士赋完成签到,获得积分10
4分钟前
John完成签到 ,获得积分10
4分钟前
Akim应助sailingluwl采纳,获得10
4分钟前
彩色的芷容完成签到 ,获得积分10
4分钟前
李爱国应助zhaochenyu采纳,获得10
4分钟前
郭磊完成签到 ,获得积分10
4分钟前
huanghe完成签到,获得积分10
4分钟前
有终完成签到 ,获得积分10
4分钟前
残忆发布了新的文献求助10
5分钟前
高分求助中
【请各位用户详细阅读此贴后再求助】科研通的精品贴汇总(请勿应助) 10000
The Mother of All Tableaux: Order, Equivalence, and Geometry in the Large-scale Structure of Optimality Theory 3000
Global Eyelash Assessment scale (GEA) 1000
Maritime Applications of Prolonged Casualty Care: Drowning and Hypothermia on an Amphibious Warship 500
Comparison analysis of Apple face ID in iPad Pro 13” with first use of metasurfaces for diffraction vs. iPhone 16 Pro 500
Towards a $2B optical metasurfaces opportunity by 2029: a cornerstone for augmented reality, an incremental innovation for imaging (YINTR24441) 500
Materials for Green Hydrogen Production 2026-2036: Technologies, Players, Forecasts 500
热门求助领域 (近24小时)
化学 材料科学 医学 生物 工程类 有机化学 生物化学 物理 内科学 纳米技术 计算机科学 化学工程 复合材料 遗传学 基因 物理化学 催化作用 冶金 细胞生物学 免疫学
热门帖子
关注 科研通微信公众号,转发送积分 4054261
求助须知:如何正确求助?哪些是违规求助? 3592211
关于积分的说明 11413913
捐赠科研通 3318351
什么是DOI,文献DOI怎么找? 1825023
邀请新用户注册赠送积分活动 896271
科研通“疑难数据库(出版商)”最低求助积分说明 817418